The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
Szymon Zmorzyński(Medical University of Lublin), Agata Filip(Medical University of Lublin), Magdalena Wojcierowska-Litwin(Medical University of Lublin), Marek Hus(Medical University of Lublin), Sylwia Popek-Marciniec(Medical University of Lublin), Aneta Szudy‐Szczyrek(Medical University of Lublin), Iwona Korszeń-Pilecka(Medical University of Lublin), Sylwia Chocholska(Medical University of Lublin), Wojciech Styk(Medical University of Lublin)
Cited by 38
Related Papers
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Therapy‐related peripheral neuropathy in multiple myeloma patients
|Hematological Oncology|2014|70